Cargando…

Risk factors of late lesion growth after acute ischemic stroke treatment

BACKGROUND: Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late,...

Descripción completa

Detalles Bibliográficos
Autores principales: Konduri, Praneeta, Bucker, Amber, Boers, Anna, Dutra, Bruna, Samuels, Noor, Treurniet, Kilian, Berkhemer, Olvert, Yoo, Albert, van Zwam, Wim, van Oostenbrugge, Robert, van der Lugt, Aad, Dippel, Diederik, Roos, Yvo, Bot, Joost, Majoie, Charles, Marquering, Henk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581245/
https://www.ncbi.nlm.nih.gov/pubmed/36277932
http://dx.doi.org/10.3389/fneur.2022.977608
_version_ 1784812577840168960
author Konduri, Praneeta
Bucker, Amber
Boers, Anna
Dutra, Bruna
Samuels, Noor
Treurniet, Kilian
Berkhemer, Olvert
Yoo, Albert
van Zwam, Wim
van Oostenbrugge, Robert
van der Lugt, Aad
Dippel, Diederik
Roos, Yvo
Bot, Joost
Majoie, Charles
Marquering, Henk
author_facet Konduri, Praneeta
Bucker, Amber
Boers, Anna
Dutra, Bruna
Samuels, Noor
Treurniet, Kilian
Berkhemer, Olvert
Yoo, Albert
van Zwam, Wim
van Oostenbrugge, Robert
van der Lugt, Aad
Dippel, Diederik
Roos, Yvo
Bot, Joost
Majoie, Charles
Marquering, Henk
author_sort Konduri, Praneeta
collection PubMed
description BACKGROUND: Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late, subacute lesion growth. METHODS: Patients from the MR CLEAN trial cohort with good quality 24 h and 1-week follow up non-contrast CT scans were included. Late Lesion growth was defined as the difference between the ischemic lesion volume assessed after 1-week and 24-h. To identify risk factors, patient characteristics associated with lesion growth (categorized in quartiles) in univariable ordinal analysis (p < 0.1) were included in a multivariable ordinal regression model. RESULTS: In the 226 patients that were included, the median lesion growth was 22 (IQR 10–45) ml. In the multivariable model, lower collateral capacity [aOR: 0.62 (95% CI: 0.44–0.87); p = 0.01], longer time to treatment [aOR: 1.04 (1–1.08); p = 0.04], unsuccessful recanalization [aOR: 0.57 (95% CI: 0.34–0.97); p = 0.04], and larger midline shift [aOR: 1.18 (95% CI: 1.02–1.36); p = 0.02] were associated with late lesion growth. CONCLUSION: Late, subacute, lesion growth occurring between 1 day and 1 week after ischemic stroke treatment is influenced by lower collateral capacity, longer time to treatment, unsuccessful recanalization, and larger midline shift. Notably, these risk factors are similar to the risk factors of acute lesion growth, suggesting that understanding and minimizing the effects of the predictors for late lesion growth could be beneficial to mitigate the effects of ischemia.
format Online
Article
Text
id pubmed-9581245
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95812452022-10-20 Risk factors of late lesion growth after acute ischemic stroke treatment Konduri, Praneeta Bucker, Amber Boers, Anna Dutra, Bruna Samuels, Noor Treurniet, Kilian Berkhemer, Olvert Yoo, Albert van Zwam, Wim van Oostenbrugge, Robert van der Lugt, Aad Dippel, Diederik Roos, Yvo Bot, Joost Majoie, Charles Marquering, Henk Front Neurol Neurology BACKGROUND: Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late, subacute lesion growth. METHODS: Patients from the MR CLEAN trial cohort with good quality 24 h and 1-week follow up non-contrast CT scans were included. Late Lesion growth was defined as the difference between the ischemic lesion volume assessed after 1-week and 24-h. To identify risk factors, patient characteristics associated with lesion growth (categorized in quartiles) in univariable ordinal analysis (p < 0.1) were included in a multivariable ordinal regression model. RESULTS: In the 226 patients that were included, the median lesion growth was 22 (IQR 10–45) ml. In the multivariable model, lower collateral capacity [aOR: 0.62 (95% CI: 0.44–0.87); p = 0.01], longer time to treatment [aOR: 1.04 (1–1.08); p = 0.04], unsuccessful recanalization [aOR: 0.57 (95% CI: 0.34–0.97); p = 0.04], and larger midline shift [aOR: 1.18 (95% CI: 1.02–1.36); p = 0.02] were associated with late lesion growth. CONCLUSION: Late, subacute, lesion growth occurring between 1 day and 1 week after ischemic stroke treatment is influenced by lower collateral capacity, longer time to treatment, unsuccessful recanalization, and larger midline shift. Notably, these risk factors are similar to the risk factors of acute lesion growth, suggesting that understanding and minimizing the effects of the predictors for late lesion growth could be beneficial to mitigate the effects of ischemia. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9581245/ /pubmed/36277932 http://dx.doi.org/10.3389/fneur.2022.977608 Text en Copyright © 2022 Konduri, Bucker, Boers, Dutra, Samuels, Treurniet, Berkhemer, Yoo, van Zwam, van Oostenbrugge, van der Lugt, Dippel, Roos, Bot, Majoie, Marquering and the MR CLEAN Trial Investigators (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Konduri, Praneeta
Bucker, Amber
Boers, Anna
Dutra, Bruna
Samuels, Noor
Treurniet, Kilian
Berkhemer, Olvert
Yoo, Albert
van Zwam, Wim
van Oostenbrugge, Robert
van der Lugt, Aad
Dippel, Diederik
Roos, Yvo
Bot, Joost
Majoie, Charles
Marquering, Henk
Risk factors of late lesion growth after acute ischemic stroke treatment
title Risk factors of late lesion growth after acute ischemic stroke treatment
title_full Risk factors of late lesion growth after acute ischemic stroke treatment
title_fullStr Risk factors of late lesion growth after acute ischemic stroke treatment
title_full_unstemmed Risk factors of late lesion growth after acute ischemic stroke treatment
title_short Risk factors of late lesion growth after acute ischemic stroke treatment
title_sort risk factors of late lesion growth after acute ischemic stroke treatment
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581245/
https://www.ncbi.nlm.nih.gov/pubmed/36277932
http://dx.doi.org/10.3389/fneur.2022.977608
work_keys_str_mv AT konduripraneeta riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT buckeramber riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT boersanna riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT dutrabruna riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT samuelsnoor riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT treurnietkilian riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT berkhemerolvert riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT yooalbert riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT vanzwamwim riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT vanoostenbruggerobert riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT vanderlugtaad riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT dippeldiederik riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT roosyvo riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT botjoost riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT majoiecharles riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT marqueringhenk riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment
AT riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment